Abstract
Patients with chronic abdominal pain without an organic basis present a difficult management problem. Some of these patients may be prescribed opiates initially which may result in requiring progressively higher doses for pain relief. In this clinical setting, the suspicion of narcotic bowel syndrome should be borne in mind. With appropriate treatment and counselling, further invasive investigations including laparotomy may be avoided and resolution of symptoms can be achieved with clonidine. This case report demonstrates such a typical clinical scenario and discusses the possible aetiology and pathophysiology of narcotic bowel syndrome as well as the role of clonidine in controlling opiate withdrawal symptoms.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bakris G. L., Cross P. D., Hammarsten J. E. The use of clonidine for management of opiate abstinence in a chronic pain patient. Mayo Clin Proc. 1982 Oct;57(10):657–660. [PubMed] [Google Scholar]
- Bianchi G., Ferretti P., Recchia M., Rocchetti M., Tavani A., Manara L. Morphine tissue levels and reduction of gastrointestinal transit in rats. Correlation supports primary action site in the gut. Gastroenterology. 1983 Oct;85(4):852–858. [PubMed] [Google Scholar]
- Burks T. F., Galligan J. J., Porreca F. Gastrointestinal drug receptors. J Clin Gastroenterol. 1983;5 (Suppl 1):29–36. doi: 10.1097/00004836-198312001-00004. [DOI] [PubMed] [Google Scholar]
- Doherty N. S., Hancock A. A. Role of alpha-2 adrenergic receptors in the control of diarrhea and intestinal motility. J Pharmacol Exp Ther. 1983 May;225(2):269–274. [PubMed] [Google Scholar]
- Gold M. S., Redmond D. E., Jr, Kleber H. D. Clonidine blocks acute opiate-withdrawal symptoms. Lancet. 1978 Sep 16;2(8090):599–602. doi: 10.1016/s0140-6736(78)92823-4. [DOI] [PubMed] [Google Scholar]
- Kuperman D. A., Sninsky C. A., Lynch D. F. Myoelectric activity of the small intestine during morphine dependence and withdrawal in rats. Am J Physiol. 1987 Apr;252(4 Pt 1):G562–G567. doi: 10.1152/ajpgi.1987.252.4.G562. [DOI] [PubMed] [Google Scholar]
- Malagelada J. R. Potential pharmacological approaches to management of gut motility disorders. Scand J Gastroenterol Suppl. 1984;96:111–126. [PubMed] [Google Scholar]
- Maruta T., Swanson D. W., Finlayson R. E. Drug abuse and dependency in patients with chronic pain. Mayo Clin Proc. 1979 Apr;54(4):241–244. [PubMed] [Google Scholar]
- McKay J. S., Linaker B. D., Turnberg L. A. Influence of opiates on ion transport across rabbit ileal mucosa. Gastroenterology. 1981 Feb;80(2):279–284. [PubMed] [Google Scholar]
- Powell D. W. Muscle or mucosa: the site of action of antidiarrheal opiates? Gastroenterology. 1981 Feb;80(2):406–408. [PubMed] [Google Scholar]
- Rang E. H., Fairbairn A. S., Acheson E. D. An enquiry into the incidence and prognosis of undiagnosed abdominal pain treated in hospital. Br J Prev Soc Med. 1970 Feb;24(1):47–51. doi: 10.1136/jech.24.1.47. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Read N. W. Speculations on the role of motility in the pathogenesis and treatment of diarrhoea. Scand J Gastroenterol Suppl. 1983;84:45–63. [PubMed] [Google Scholar]
- Rogers M., Cerda J. J. The narcotic bowel syndrome. J Clin Gastroenterol. 1989 Apr;11(2):132–135. [PubMed] [Google Scholar]
- Sandgren J. E., McPhee M. S., Greenberger N. J. Narcotic bowel syndrome treated with clonidine. Resolution of abdominal pain and intestinal pseudo-obstruction. Ann Intern Med. 1984 Sep;101(3):331–334. doi: 10.7326/0003-4819-101-3-331. [DOI] [PubMed] [Google Scholar]
- Schreier W. A., Burks T. F. Suppression of morphine withdrawal diarrhea by clonidine. Proc West Pharmacol Soc. 1981;24:341–345. [PubMed] [Google Scholar]
- Turnberg L. A. Antisecretory activity of opiates in vitro and in vivo in man. Scand J Gastroenterol Suppl. 1983;84:79–83. [PubMed] [Google Scholar]